[1]刘建国,安丽青,程劲光,等.纤维支气管镜下植入125I粒子治疗中央型肺癌[J].国际放射医学核医学杂志,2009,33(5):291-292.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.011]
 LIU Jian-guo,AN Li-qing,CHENG Jin-guang,et al.Efficacies of 125I seed implantation in advanced stage central lung cancer via fibrobronchoscope[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(5):291-292.[doi:10.3760/cnla.j.issn.1673-4114.2009.05.011]
点击复制

纤维支气管镜下植入125I粒子治疗中央型肺癌(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
33
期数:
2009年第5期
页码:
291-292
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Efficacies of 125I seed implantation in advanced stage central lung cancer via fibrobronchoscope
作者:
刘建国 安丽青 程劲光 张玉芬 郭晓奎
山西省晋中市第一人民医院呼吸科, 030600
Author(s):
LIU Jian-guo AN Li-qing CHENG Jin-guang ZHANG Yu-fen GUO Xiao-kui
Department of Respiratory Medicine, Shanxi Jinzhong First People’s Hospital, Shanxi Jinzhong 030600, China
关键词:
肺肿瘤碘放射性同位素近距离放射疗法支气管镜检查
Keywords:
hung neoplasmsIodine radioisopesBrachytherapyBronchoscopy
DOI:
10.3760/cnla.j.issn.1673-4114.2009.05.011
摘要:
目的 评估植入125I粒子治疗中央型肺癌的临床价值。方法 56例确诊的晚期中央型肺癌患者,经纤维支气管镜引导植入125I粒子,定期复查,观察疗效及不良反应。结果 56例中央型肺癌患者经治疗总有效率达76.78%,肺不张复张有效率为90.90%。结论 125I粒子经纤维支气管镜植入治疗晚期中央型肺癌有效,且安全可行。
Abstract:
Objective To explore the temporal curative effect of 125I seed implantation in advanced stage central type lung cancer.Methods 125I seed was implanted in 56 patients confirmed advanced stage central type lung cancer via fibrobronchoscope and all cases were fellow up in certain duration to explore their efficacies and the adverse reaction.Results Total efficient rate was 76.78% in 56 patients.Lung reexpanded rate was 90.90%.Conclusion The therapy of 125I seed implantation in advanced stage central type lung cancer is safe and available.

参考文献/References:

[1] 罗开元,李波,杨嵘,等.125I粒子组织间放射治疗恶性肿瘤的临床应用.中华医学杂志,2001,81(12):754-755.
[2] 申文江,王绿化,夏延毅.放射治疗学新技术进展.北京:北京科学技术出版社,2003:155-159.
[3] Lee W,Daly BD,Dipetrillo TA,et al.Limited resection for non-small cell lung cancer:observed local control with implantation of I-125 brachytherapy seeds.Ann Thorac Surg,2003,75(1):237-242.
[4] 王荣福.核医学.北京:北京大学医学出版社,2003:177-178.

相似文献/References:

[1]梁雯丽,郑艳,李娜,等.Graves甲亢患者131I治疗后早期TRAb及TSAb变化的研究分析[J].国际放射医学核医学杂志,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
 Liang Wenli,Zheng Yan,Li Na,et al.Analysis of the changes in early TRAb and TSAb after 131I treatment for patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
[2]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
 Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[3]邓艳,张伟.125I-碘酞酸盐临床应用进展[J].国际放射医学核医学杂志,2016,40(3):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
 Deng Yan,Zhang Wei.125I-iothalamate clinical applications[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
[4]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
 Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[5]杨珂,唐波,于夕荣,等.甲状腺癌131i治疗病房的辐射屏蔽计算与评价[J].国际放射医学核医学杂志,2015,39(5):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
 yang ke,tang bo,yu xirong,et al.shielding calculation and assessment in 131i therapy for thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
[6]霍小东,王慧星,阎卫亮,等.血管内皮抑制素对125I近距离照射裸鼠肺癌移植瘤的增敏效应研究[J].国际放射医学核医学杂志,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
 Huo Xiaodong,Wang Huixing,Yan Weiliang,et al.Sensitization effect of endostatin for 125I brachytherapy on transplanted tumor in nude mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
[7]刘娇,程兵,常伟,等.非高危分化型甲状腺癌低剂量和高剂量131I清甲疗效的分析[J].国际放射医学核医学杂志,2016,40(6):419.[doi:10.3760/cma.j.issn.1673-4114.2016.06.004]
 Liu Jiao,Cheng Bing,Chang Wei,et al.Ablation efficacy in non-high-risk differentiated thyroid carcinoma patients with low-dose and high-dose 131I[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):419.[doi:10.3760/cma.j.issn.1673-4114.2016.06.004]
[8]徐蓉生,梅艳,赵力威,等.B超引导下术中125I粒子植入治疗晚期胰腺癌的疗效评价[J].国际放射医学核医学杂志,2016,40(6):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
 Xu Rongsheng,Mei Yan,Zhao Liwei,et al.Evaluation of 125I particle implantation in the treatment of patients with advanced pancreatic neoplasms using B ultrasound-guided surgery[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
[9]王越,晋建华,李思进,等.甲状腺24h摄碘率与131I治疗Graves甲亢疗效相关性研究[J].国际放射医学核医学杂志,2015,39(6):442.[doi:10.3760/cma.j.issn.1673-4114.2015.06.002]
 Wang Yue,Jin Jianhua,Li Sijin,et al.Correlation between thyroid 24 h of radioactive iodine uptake and clinical efficacy of 131I therapy for Graves’ hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):442.[doi:10.3760/cma.j.issn.1673-4114.2015.06.002]
[10]郭坤,高蕊,于燕,等.表皮生长因子受体基因表达与甲状腺功能亢进症131I治疗预后的关系[J].国际放射医学核医学杂志,2015,39(1):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
 Guo Kun,Gao Rui,Yu Yan,et al.The relationship between epidermal growth factor receptor mRNA expression and the efficacv of 131I treatment in hyperthyroidism patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
[11]张俊涛.晚期肺癌125I粒子植入治疗近期疗效观察[J].国际放射医学核医学杂志,2014,38(2):94.[doi:10.3760/cma.j.issn.1673-4114.2014.02.006]
 Zhang Juntao.Short-term efficacy of 125I seeds implantation in the treatment of advanced lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):94.[doi:10.3760/cma.j.issn.1673-4114.2014.02.006]
[12]廖江荣,蒲德利,程毅力,等.经纤支镜和经皮联合植入125I粒子治疗晚期肺癌气管狭窄的临床分析[J].国际放射医学核医学杂志,2013,37(3):165.[doi:10.3760/cma.j.issn.1673-4114.2013.03.009]
 LIAO Jiang-rong,PU De-li,CHENG Yi-li,et al.The clinical analysis of 125I particles implantation by fibrobronchoscope and percutaneous in the treatment of tracheal stenosis of advanced lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):165.[doi:10.3760/cma.j.issn.1673-4114.2013.03.009]
[13]胡丽丽,李小东,张雪宁,等.影像引导下125I粒子植入治疗肺癌的疗效分析[J].国际放射医学核医学杂志,2013,37(4):203.[doi:10.3760/cma.j.issn.1673-4114.2013.04.004]
 HU Li-li,LI Xiao-dong,ZHANG Xue-ning,et al.Efficacy of CT guided radioactive 125I seed implantation in the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):203.[doi:10.3760/cma.j.issn.1673-4114.2013.04.004]
[14]姚红霞,张金山.微波消融和131I-肿瘤细胞核人鼠嵌合单克隆抗体联合治疗肺癌[J].国际放射医学核医学杂志,2012,36(5):264.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.002]
 YAO Hong-xia,ZHA NG Jin-shan.Combination of microwave ablation and 131I labeled tumor necrosis therapy chimeric antibody in the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):264.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.002]
[15]朱晓珉,方文岩,陈军,等.CT导向下125I粒子植入治疗难治生肺癌的疗效观察[J].国际放射医学核医学杂志,2011,35(2):114.[doi:10.3760/cma.j.issn.1673-4114.2011.02.012]
 ZHU Xiao-min,FANG Wen-yan,CHEN Jun,et al.CT guided interstitial 125I seed implantation treatment of refractory lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):114.[doi:10.3760/cma.j.issn.1673-4114.2011.02.012]
[16]张金山,邓咏梅.射频消融术和131I-肿瘤细胞核人鼠嵌合单抗治疗肺癌[J].国际放射医学核医学杂志,2009,33(3):159.[doi:10.3760/cma.j.issn.1673-4114.2009.03.008]
 ZHA NG din-shan,DENG Yong-mei.Radiofrequency ablation and Iodine-131 labeled nuclei of tumor cells chimeric monoclonal antibody radioimmunotherapy for the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(5):159.[doi:10.3760/cma.j.issn.1673-4114.2009.03.008]

备注/Memo

备注/Memo:
收稿日期:2009-05-22。
通讯作者:刘建国(E-mail:liujianguo1965@yahoo.com.cn)
更新日期/Last Update: 1900-01-01